Traditional Chinese Medicine Prolongs Progression-Free Survival and Enhances Therapeutic Effects in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)Treated Non-Small-Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations

BACKGROUND: Lung cancer is the most common cause of cancer-associated deaths worldwide. This study aimed to investigate the efficacy and safety of Traditional Chinese Medicine combining EGFR-TKIs in treatment of NSCLC patients harboring EGFR mutations. MATERIAL/METHODS: This study involved 153 advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Mo, Wang, Shumei, Zhao, Bin, Wang, Wei, Zhu, Yuxi, Hu, Lingjing, Zhang, Xianquan, Xiong, Shaoquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865232/
https://www.ncbi.nlm.nih.gov/pubmed/31704907
http://dx.doi.org/10.12659/MSM.917251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865232/
https://www.ncbi.nlm.nih.gov/pubmed/31704907
http://dx.doi.org/10.12659/MSM.917251

Ejemplares similares